Insulin and Insulin-like Growth Factor-I Receptors in Astrocytes Exert Different Effects on Behavior and Alzheimer´s-like Pathology
Overview
Authors
Affiliations
Pleiotropic actions of insulin and insulin-like growth factor I (IGF-I) in the brain are context- and cell-dependent, but whether this holds for their receptors (insulin receptor (IR) and IGF-I receptor (IGF-IR), respectively), is less clear. We compared mice lacking IR or IGF-IR in glial fibrillary astrocytic protein (GFAP)-expressing astrocytes in a tamoxifen-regulated manner, to clarify their role in this type of glial cells, as the majority of data of their actions in brain have been obtained in neurons. We observed that mice lacking IR in GFAP astrocytes (GFAP IR KO mice) develop mood disturbances and maintained intact cognition, while at the same time show greater pathology when cross-bred with APP/PS1 mice, a model of familial Alzheimer´s disease (AD). Conversely, mice lacking IGF-IR in GFAP astrocytes (GFAP-IGF-IR KO mice) show cognitive disturbances, maintained mood tone, and show control-dependent changes in AD-like pathology. These observations confirm that the role of IR and IGF-IR in the brain is cell-specific and context-dependent.
The signaling landscape of insulin-like growth factor 1.
Khan M, Zugaza J, Torres Aleman I J Biol Chem. 2024; 301(1):108047.
PMID: 39638246 PMC: 11748690. DOI: 10.1016/j.jbc.2024.108047.
Role of the Insulin-like Growth Factor System in Neurodegenerative Disease.
Lewitt M, Boyd G Int J Mol Sci. 2024; 25(8).
PMID: 38674097 PMC: 11049992. DOI: 10.3390/ijms25084512.
Wang S, Hou K, Gui S, Ma Y, Wang S, Zhao S Stress Biol. 2023; 3(1):23.
PMID: 37676529 PMC: 10441889. DOI: 10.1007/s44154-023-00105-1.
State of the Science on Brain Insulin Resistance and Cognitive Decline Due to Alzheimer's Disease.
Rhea E, Leclerc M, Yassine H, Capuano A, Tong H, Petyuk V Aging Dis. 2023; 15(4):1688-1725.
PMID: 37611907 PMC: 11272209. DOI: 10.14336/AD.2023.0814.
Nunez A, Zegarra-Valdivia J, Fernandez de Sevilla D, Pignatelli J, Torres Aleman I Mol Psychiatry. 2023; 28(8):3220-3230.
PMID: 37353586 DOI: 10.1038/s41380-023-02136-6.